Vaginal Health

• Clinically proven to suppress Candida growth by 52-73% and improve bacterial vaginosis culture results in 59% of women

• Reduces recurrent UTI frequency from 6.8 to 3.3 infections per year through competitive pathogen exclusion

• Normalizes vaginal microbiome profiles in 90% of women with healthy flora restoration in 61.2% versus 26.85% placebo

• Clinically proven to suppress Candida growth by 52-73% and improve bacterial vaginosis culture results in 59% of women

• Reduces recurrent UTI frequency from 6.8 to 3.3 infections per year through targeted urogenital support

• Restores healthy vaginal flora in 61.2% of women compared to 26.85% with placebo treatment

• Contains polygodial that causes direct structural damage to Candida cell membranes

• Clinically shown to be as effective as conventional azole treatments for Candida infections

• Demonstrates twice the effectiveness at preventing infection recurrence compared to standard antifungals

• Caprylic acid downregulates Candida yeast-to-hyphae transformation pathways by 5208 fold, preventing tissue invasion

• Medium-chain triglycerides physically disrupt fungal cell membranes causing cell disintegration

• Clinically shown to be as effective as conventional azole medications for Candida treatment

• Black seed oil shows 5-fold reduction in kidney Candida, 8-fold in liver, and 11-fold in spleen through nitric oxide pathways

• Garlic's ajoene compound demonstrates strongest anti-Candida activity by suppressing dangerous hyphae formation

• Clove oil's 90% eugenol content destroys Candida cell membranes and prevents biofilm formation in clinical trials

• Reduces recurrent UTI frequency from 6.8 to 3.3 infections per year with GR-1 + RC-14 strains

• Suppresses Candida growth by 52-73% and improves bacterial vaginosis outcomes in 88% vs 40% placebo

• Normalises vaginal microbiome in 90% of women and restores healthy flora in 61% vs 27% placebo